Studies have also shown that SAA reverses paclitaxel resistance in human breast cancer [50], reduces MMP-2 expression, and inhibits p-ERK protein expression in human nasopharyngeal carcinoma cells [51] and oral squamous cell carcinoma [52]. Here, MMP2 is linked to oral cavity squamous cell carcinoma.